Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis.

Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X.

Diagn Pathol. 2013 Oct 31;8:180. doi: 10.1186/1746-1596-8-180. Review.

2.

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis.

Yin S, Bai H, Jing D.

Diagn Pathol. 2014 May 12;9:91. doi: 10.1186/1746-1596-9-91. Review.

3.

Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.

Karlstad O, Starup-Linde J, Vestergaard P, Hjellvik V, Bazelier MT, Schmidt MK, Andersen M, Auvinen A, Haukka J, Furu K, de Vries F, De Bruin ML.

Curr Drug Saf. 2013 Nov;8(5):333-48. Review.

4.

CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.

Starup-Linde J, Karlstad O, Eriksen SA, Vestergaard P, Bronsveld HK, de Vries F, Andersen M, Auvinen A, Haukka J, Hjellvik V, Bazelier MT, Boer Ad, Furu K, De Bruin ML.

Curr Drug Saf. 2013 Nov;8(5):296-332. Review.

PMID:
24215312
5.

Systematic review and meta-analysis of insulin therapy and risk of cancer.

Janghorbani M, Dehghani M, Salehi-Marzijarani M.

Horm Cancer. 2012 Aug;3(4):137-46. doi: 10.1007/s12672-012-0112-z. Review.

PMID:
22528451
6.

Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.

Bu WJ, Song L, Zhao DY, Guo B, Liu J.

Br J Clin Pharmacol. 2014 Aug;78(2):301-9. doi: 10.1111/bcp.12350.

7.

Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

Larsson SC, Orsini N, Wolk A.

J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87.

8.

Insulin and risk of diabetic retinopathy in patients with type 2 diabetes mellitus: data from a meta-analysis of seven cohort studies.

Zhao C, Wang W, Xu D, Li H, Li M, Wang F.

Diagn Pathol. 2014 Jun 27;9:130. doi: 10.1186/1746-1596-9-130.

9.

Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

Singh S, Singh PP, Singh AG, Murad MH, McWilliams RR, Chari ST.

Am J Gastroenterol. 2013 Apr;108(4):510-9; quiz 520. doi: 10.1038/ajg.2013.7. Review.

PMID:
23399556
10.

Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies.

Chen YB, Chen Q, Wang Z, Zhou J.

PLoS One. 2013 Nov 25;8(11):e81594. doi: 10.1371/journal.pone.0081594. Review.

11.
12.

Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis.

Deng L, Gui Z, Zhao L, Wang J, Shen L.

Dig Dis Sci. 2012 Jun;57(6):1576-85. doi: 10.1007/s10620-012-2055-1. Review.

PMID:
22350783
13.

Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis.

Luo S, Li JY, Zhao LN, Yu T, Zhong W, Xia ZS, Shan TD, Ouyang H, Yang HS, Chen QK.

Clin Res Hepatol Gastroenterol. 2016 Feb;40(1):110-23. doi: 10.1016/j.clinre.2015.05.021.

PMID:
26162991
14.

Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

Singh S, Singh H, Singh PP, Murad MH, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2258-68. doi: 10.1158/1055-9965.EPI-13-0429. Review.

15.

Insulin therapy and risk of colorectal cancer: an updated meta-analysis of epidemiological studies.

Sun A, Liu R, Sun G.

Curr Med Res Opin. 2014 Mar;30(3):423-30. doi: 10.1185/03007995.2013.858622.

PMID:
24156655
16.
17.

Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.

Zhang ZJ, Zheng ZJ, Kan H, Song Y, Cui W, Zhao G, Kip KE.

Diabetes Care. 2011 Oct;34(10):2323-8. doi: 10.2337/dc11-0512. Review.

18.

Diabetes and the risk for colorectal cancer.

Erbach M, Mehnert H, Schnell O.

J Diabetes Complications. 2012 Jan-Feb;26(1):50-5. doi: 10.1016/j.jdiacomp.2011.11.003. Review.

PMID:
22321219
19.

Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis.

Ren HB, Yu T, Liu C, Li YQ.

Cancer Causes Control. 2011 Jun;22(6):837-47. doi: 10.1007/s10552-011-9754-3. Review.

PMID:
21424210
20.

Diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies.

Lee JY, Jeon I, Kim JW, Song YS, Yoon JM, Park SM.

Int J Gynecol Cancer. 2013 Mar;23(3):402-12. doi: 10.1097/IGC.0b013e31828189b2. Review.

PMID:
23354371
Items per page

Supplemental Content

Support Center